SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-059747
Filing Date
2023-11-07
Accepted
2023-11-07 07:00:22
Documents
53
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-20230930.htm   iXBRL 10-Q 1315332
2 EX-10.1 nerv-ex10_1.htm EX-10.1 20274
3 EX-10.2 nerv-ex10_2.htm EX-10.2 270352
4 EX-31.1 nerv-ex31_1.htm EX-31.1 16601
5 EX-31.2 nerv-ex31_2.htm EX-31.2 16074
6 EX-32.1 nerv-ex32_1.htm EX-32.1 13909
  Complete submission text file 0000950170-23-059747.txt   5261197

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nerv-20230930_lab.xml EX-101.LAB 324604
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nerv-20230930_def.xml EX-101.DEF 149985
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nerv-20230930_cal.xml EX-101.CAL 25136
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nerv-20230930_pre.xml EX-101.PRE 250152
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nerv-20230930.xsd EX-101.SCH 40164
47 EXTRACTED XBRL INSTANCE DOCUMENT nerv-20230930_htm.xml XML 664497
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 231381487
SIC: 2834 Pharmaceutical Preparations